Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it has enclosed the schedule of Analyst/ Institutional Investor Meetings with the Company on 23rd January 2021 with Motilal Oswal Financial Services. The schedule of the above-mentioned meeting is subject to change and the change may occur due to exigencies on the part of Investor/ Analyst/ Company.
The above information is a part of company’s filings submitted to BSE.
